B6;129-Rev3ltm1Crey/Cnbc
Status | Available to order |
EMMA ID | EM:10791 |
International strain name | B6;129-Rev3ltm1Crey/Cnbc |
Alternative name | B6-129-Rev3L(catlytic mutant) |
Strain type | Targeted Mutant Strains : Knock-in |
Allele/Transgene symbol | Rev3ltm1Crey, |
Gene/Transgene symbol | Rev3l |
Information from provider
Provider | Claude-Agnes Reynaud |
Provider affiliation | INSERM U1151/CNRS UMR 8253, Institut Necker-Enfants Malades |
Genetic information | Knock-in mutations of the catalytic site of Rev3l DNA polymerase. |
Phenotypic information | Homozygous:No obvious phenotype.Heterozygous:No obvious phenotype |
References |
|
Homozygous fertile | yes |
Homozygous viable | yes |
Homozygous matings required | no |
Immunocompromised | no |
Information from EMMA
Archiving centre | CNB-CSIC, Centro Nacional de Biotecnologia, Madrid, Spain |
Animals used for archiving | homozygous C57BL/6;129 |
Disease and phenotype information
Orphanet associated rare diseases, based on orthologous gene matching
- Moebius syndrome / Orphanet_570
Literature references
- A single aspartate mutation in the conserved catalytic site of Rev3L generates a hypomorphic phenotype in vivo and in vitro.;Fritzen Rémi, Delbos Frédéric, De Smet Annie, Palancade Benoît, Canman Christine E, Aoufouchi Said, Weill Jean-Claude, Reynaud Claude-Agnès, Storck Sébastien, ;2016;DNA repair;46;37-46; 27481099
INFRAFRONTIER® and European Mouse Mutant Archive - EMMA® are registered trademarks at the European Union Intellectual Property Office (EUIPO).